Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/06/2841292/0/en/23andMe-Launches-New-Genetic-Reports-on-Common-Forms-of-Cancer.html
https://www.globenewswire.com//news-release/2024/03/05/2840938/0/en/23andMe-Announces-Three-Presentations-from-Clinical-Stage-Immuno-Oncology-Programs-at-the-American-Association-for-Cancer-Research-AACR-Annual-Meeting-2024.html
https://www.globenewswire.com//news-release/2024/02/07/2825537/0/en/23andMe-Reports-Third-Quarter-Fiscal-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/01/31/2820995/0/en/23andMe-Announces-FDA-Clearance-of-IND-Application-for-its-Dual-Mechanism-Antibody-23ME-01473-Targeting-ULBP6.html
https://www.globenewswire.com/news-release/2024/01/31/2820684/0/en/23andMe-Launches-Month-Long-Initiative-to-Amplify-ARRAY-s-Seat16-Program-for-Acclaimed-Film-ORIGIN-by-Ava-DuVernay.html
https://www.globenewswire.com//news-release/2024/01/24/2816059/0/en/23andMe-to-Report-FY2024-Third-Quarter-Financial-Results.html
https://www.globenewswire.com//news-release/2023/12/19/2798489/0/en/23andMe-announces-further-expansion-of-23ME-00610-Phase-1-2a-clinical-trial-in-advanced-neuroendocrine-and-ovarian-cancer-patient-cohorts.html
https://www.globenewswire.com//news-release/2023/11/08/2776690/0/en/23andMe-Reports-Second-Quarter-Fiscal-2024-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/07/2775056/0/en/23andMe-Launches-Total-Health-its-Comprehensive-Prevention-Based-Health-Membership.html
https://www.globenewswire.com//news-release/2023/11/06/2774033/0/en/23andMe-Announces-Updated-Safety-and-Preliminary-Efficacy-Data-From-the-Phase-1-2a-Study-of-23ME-00610-an-Investigational-Antibody-Targeting-CD200R1.html